Detalles de la búsqueda
1.
A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma.
Blood
; 142(7): 621-628, 2023 08 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37319432
2.
Atrial arrhythmias following CAR-chimeric antigen receptor T-cell therapy: Incidence, risk factors and biomarker profile.
Br J Haematol
; 2024 May 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38735683
3.
The Simplified Comorbidity Index predicts non-relapse mortality in reduced-intensity conditioning allogeneic haematopoietic cell transplantation.
Br J Haematol
; 203(5): 840-851, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37614192
4.
Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study.
Blood
; 137(11): 1527-1537, 2021 03 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33512409
5.
PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation.
Blood
; 134(1): 22-29, 2019 07 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30952672
6.
Stem Cell Mobilization and Autograft Minimal Residual Disease Negativity with Novel Induction Regimens in Multiple Myeloma.
Biol Blood Marrow Transplant
; 26(8): 1394-1401, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32442725
7.
Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic.
Biol Blood Marrow Transplant
; 26(7): 1239-1246, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32298807
8.
Prognostic Factors for Postrelapse Survival after ex Vivo CD34+-Selected (T Cell-Depleted) Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma.
Biol Blood Marrow Transplant
; 26(11): 2040-2046, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32712326
9.
Ex Vivo T Cell-Depleted Hematopoietic Stem Cell Transplantation for Adult Patients with Acute Myelogenous Leukemia in First and Second Remission: Long-Term Disease-Free Survival with a Significantly Reduced Risk of Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 26(2): 323-332, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31618690
10.
Early experience using salvage radiotherapy for relapsed/refractory non-Hodgkin lymphomas after CD19 chimeric antigen receptor (CAR) T cell therapy.
Br J Haematol
; 190(1): 45-51, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32135029
11.
Impact of type of reduced-intensity conditioning regimen on the outcomes of allogeneic haematopoietic cell transplantation in classical Hodgkin lymphoma.
Br J Haematol
; 190(4): 573-582, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32314807
12.
BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation.
Am J Hematol
; 99(6): 1180-1183, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38526002
13.
Survival outcomes of allogeneic hematopoietic cell transplants with EBV-positive or EBV-negative post-transplant lymphoproliferative disorder, A CIBMTR study.
Transpl Infect Dis
; 21(5): e13145, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31301099
14.
Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure.
Cancer
; 124(12): 2541-2551, 2018 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29645093
15.
A Comprehensive Assessment of Toxicities in Patients with Central Nervous System Lymphoma Undergoing Autologous Stem Cell Transplantation Using Thiotepa, Busulfan, and Cyclophosphamide Conditioning.
Biol Blood Marrow Transplant
; 23(1): 38-43, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27713090
16.
Prospective Evaluation of Unrelated Donor Cord Blood and Haploidentical Donor Access Reveals Graft Availability Varies by Patient Ancestry: Practical Implications for Donor Selection.
Biol Blood Marrow Transplant
; 23(6): 965-970, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28263918
17.
T Cell Depletion as an Alternative Approach for Patients 55 Years or Older Undergoing Allogeneic Stem Cell Transplantation as Curative Therapy for Hematologic Malignancies.
Biol Blood Marrow Transplant
; 23(10): 1685-1694, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28734876
18.
The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation.
Blood
; 124(7): 1174-82, 2014 Aug 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-24939656
19.
Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma.
Haematologica
; 106(1): 255-258, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32079691
20.
High Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell-Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous Leukemia.
Biol Blood Marrow Transplant
; 21(11): 1985-93, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26238810